Filter your results
- 3
- 2
- 5
- 5
- 1
- 2
- 1
- 1
- 5
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 5
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Blood Advances, 2019, 3 (24), pp.4238-4251. ⟨10.1182/bloodadvances.2019000647⟩
Journal articles
hal-02442440v1
|
||
|
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.Hepatology, 2007, 45 (4), pp.957-67. ⟨10.1002/hep.21536⟩
Journal articles
hal-00690471v1
|
||
A simple clinical and biological score to promote and enhance Ferroportine disease screening.Hepatology, 2017, 66, pp.430A-431A
Journal articles
hal-01671423v1
|
|||
|
The anti-fibrotic role of mast cells in the liver is mediated by HLA-G and interaction with hepatic stellate cellsCytokine, 2019, 117, pp.50-58. ⟨10.1016/j.cyto.2019.02.002⟩
Journal articles
hal-02061957v1
|
||
|
A simple clinical score to promote and enhance ferroportin disease screeningJournal of Hepatology, 2022, 76 (3), pp.568-576. ⟨10.1016/j.jhep.2021.10.022⟩
Journal articles
hal-03467768v1
|